Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM.

From the Department of Neurology (E.R.D., R.C., K.M.B., R.G.H., K.K., F.J.M., B.M.R., G.S.), University of Rochester Medical Center, and School of Public Health (J.P.T.), University of Rochester, NY, Department of Neurology (A.S.), University of Pennsylvania Medical Center, Philadelphia, PA, and Parkinson's Institute (C.M.T.), Sunnyvale, CA. R.C. is currently with the Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Abstract-- Based on published prevalence studies, we used two different methodologies to project the number of individuals with Parkinson disease (PD) in Western Europe's 5 most and the world's 10 most populous nations. The number of individuals with PD over age 50 in these countries was between 4.1 and 4.6 million in 2005 and will double to between 8.7 and 9.3 million by 2030.

PMID: 17082464 [PubMed - as supplied by publisher]